Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient

Jesus Vera-Aguilera, MD
Narjust Duma, MD
Kelly Gast, MD
Hassan Alkhateeb, MD
Aaron Tande, MD
Nelson Leung, MD
William J. Hogan, MB ChB
Saad J. Kenderian, MB ChB

Open link

Publication date

December 2018

DOI

10.1016/j.mayocpiqo.2018.07.001

Publisher

Elsevier BV

ISSN

2542-4548

Journal

Mayo Clinic Proceedings Innovations Quality & Outcomes

Abstract

We report the development of a Shiga toxin–producing Escherichia coli O157 gastrointestinal infection associated with hemolytic uremic syndrome in an allogenic stem cell transplant recipient with a history of gastrointestinal graft-vs-host disease receiving long-term immunosuppression

Extracted data

We use cookies to provide a better user experience.

Data Protection

Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient

Abstract

Extracted data

Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient

Abstract

Extracted data

Related items

Related items